Accuray (ARAY) Total Debt Growth (1y) (2012 - 2026)
Accuray (ARAY) Total Debt Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 0.12% |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -5.76% |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 19.06% |
| 10 | Accuray | 28,179.72 | -38.51 Mn | 25.29 Mn | -16.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.46% |
| Dec 31, 2025 | -22.58% |
| Sep 30, 2025 | -17.66% |
| Jun 30, 2025 | -20.70% |
| Mar 31, 2025 | 0.17% |
| Dec 31, 2024 | 0.43% |
| Sep 30, 2024 | -3.28% |
| Jun 30, 2024 | -2.89% |
| Mar 31, 2024 | -2.83% |
| Dec 31, 2023 | -2.81% |
| Sep 30, 2023 | -0.17% |
| Jun 30, 2023 | -1.77% |
| Mar 31, 2023 | -1.49% |
| Dec 31, 2022 | -1.22% |
| Sep 30, 2022 | -10.86% |
| Jun 30, 2022 | 3.84% |
| Mar 31, 2022 | -0.98% |
| Dec 31, 2021 | 0.79% |
| Sep 30, 2021 | 10.08% |
| Jun 30, 2021 | -8.19% |